Advanced Cancer Therapeutics, LLC – Trademark Portfolio
Entity Type: 16
Advanced Cancer Therapeutics, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ADVANCED CANCER THERAPEUTICS. The owner is based in Louisville, KY.
Suite 600
Louisville, KY 40202
Showing of trademarks Trademarks
Trademark Classifications
Advanced Cancer Therapeutics, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Advanced Cancer Therapeutics, LLC have?
Advanced Cancer Therapeutics, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Advanced Cancer Therapeutics, LLC file in?
Advanced Cancer Therapeutics, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Advanced Cancer Therapeutics, LLC's most well-known trademarks?
Advanced Cancer Therapeutics, LLC's registered trademark portfolio includes well-known marks such as ADVANCED CANCER THERAPEUTICS. These are among 1 currently registered trademark in the portfolio.
What is Advanced Cancer Therapeutics, LLC's trademark registration success rate?
Advanced Cancer Therapeutics, LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.